Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer
Completed · Phase 2
Conditions studied: Breast Cancer
In brief
This study determines the proportion of metastatic breast cancer patients progression free after 6 months when treated with gemcitabine/ cisplatin/ trastuzumab or gemcitabine/ trastuzumab.
Key facts
- Study ID
- NCT00201760
- Run by
- Kari Kendra
- People needed
- 10
- Starts
- 2005-02-25
- Expected to finish
- 2009-10-31
- Last updated by the study team
- 2017-12-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Ohio State University — Columbus, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.